Twin anemia-polycythemia sequence is a complication that can affect identical twins who share one placenta during pregnancy. In twin anemia-polycythemia sequence, one twin becomes anemic and the other develops too many red blood cells, and early signs of twin anemia-polycythemia sequence may only show up on ultrasound or blood flow checks. It usually develops before birth, but some babies are diagnosed at delivery or shortly after. Not everyone will have the same experience, and severe twin anemia-polycythemia sequence can be life-threatening for one or both twins if it is not treated. Treatment depends on timing and severity and may include close monitoring, laser treatment of placental blood vessel connections, blood transfusion or partial exchange transfusion, or delivery when it is safer for the babies to be born.
How many people live with Twin anemia-polycythemia sequence?
Direct head counts are not routinely reported for twin anemia-polycythemia sequence because it happens during pregnancy, but with about 1.6 million twin pairs born worldwide each year (Monden et al., 2021) and TAPS affecting about 3-5% of twins who share one placenta, this suggests roughly 10,000-16,000 affected pregnancies worldwide each year, which is an estimate rather than a direct count (ISUOG, 2023). In the United States, about 100,000 babies are born as twins each year (CDC National Center for Health Statistics, 2024), which works out to roughly 300-500 TAPS pregnancies a year by the same method, again as an estimate rather than a direct count (ISUOG, 2023).
Overview
Twin anemia-polycythemia sequenceSymptoms
Twin anemia-polycythemia sequence often causes no symptoms for the pregnant parent and is usually found on ultrasound. One twin may show signs of anemia, while the other has too many red blood cells, which can lead to poor growth or stress before birth.
Outlook and prognosis
With Twin anemia-polycythemia sequence, outlook depends on how early it is found and treated during pregnancy. Many babies do well after prompt care, though some need close monitoring after birth. Earlier diagnosis often improves Twin anemia-polycythemia sequence outcomes.
Causes and risk factors
Twin anemia-polycythemia sequence happens in some identical twins who share one placenta. It is linked to a few very small blood-vessel connections in that placenta, sometimes occurring naturally and sometimes after laser treatment for twin-to-twin transfusion syndrome.
Genetic influences
Genetics are not thought to play a major role in Twin anemia-polycythemia sequence. It usually happens because of shared placental blood vessel connections in identical twins, rather than an inherited gene change.
Diagnosis
Twin anemia-polycythemia sequence is usually diagnosed during pregnancy with ultrasound and Doppler blood flow checks, often supported by different middle cerebral artery readings in each twin. After birth, blood tests can confirm the diagnosis of Twin anemia-polycythemia sequence.
Treatment and drugs
Twin anemia-polycythemia sequence is treated by close ultrasound monitoring and, when needed, laser treatment to seal shared placental blood vessels. Some babies need blood transfusion before birth. Earlier delivery may be safest in severe cases.
Symptoms
During a twin pregnancy, Twin anemia-polycythemia sequence often causes few clear symptoms for the pregnant parent. The early symptoms of Twin anemia-polycythemia sequence are more often signs on ultrasound or differences between the babies after birth than something you can easily feel day to day. One twin may become anemic, which can make them pale, weak, or short of breath, while the other may have thicker blood and look unusually red or seem very sleepy. Because these changes can be subtle, the condition is often picked up during specialist monitoring.
During pregnancy, many people do not notice obvious symptoms. Twin anemia-polycythemia sequence is often found during close ultrasound monitoring or when the babies look different after delivery.
One baby, usually the anemic twin, may move less if the anemia becomes significant. A clear drop in movement late in pregnancy should be checked right away.
The anemic twin may look pale, seem low-energy, or tire quickly with feeds after birth. Poor feeding, limpness, or a faint cry can be clues that the body is not getting enough oxygen.
Anemia can make the anemic twin breathe faster or work harder to breathe. In more severe cases, the heart may be under strain and urgent support may be needed.
How people usually first notice Twin anemia-polycythemia sequence?
Twin anemia-polycythemia sequence is usually first noticed during routine ultrasound checks in a monochorionic twin pregnancy, often before a pregnant person feels anything unusual. Doctors may see one twin showing signs of anemia, meaning too few red blood cells, while the other has signs of polycythemia, meaning too many red blood cells, often picked up by a special blood-flow ultrasound called Doppler rather than by obvious symptoms. In some pregnancies, the first signs of twin anemia-polycythemia sequence appear later as one or both twins seem to grow differently or show stress on monitoring, which is why close follow-up is so important.
Types of Twin anemia-polycythemia sequence
Twin anemia-polycythemia sequence is a pregnancy complication in identical twins who share one placenta, and the main variations are based on how and when it develops. In practice, doctors usually talk about spontaneous twin anemia-polycythemia sequence and twin anemia-polycythemia sequence that appears after laser treatment for twin-to-twin transfusion syndrome. Symptoms don’t always look the same for everyone. In many pregnancies, early symptoms of twin anemia-polycythemia sequence are subtle, and the differences are picked up on ultrasound or after birth rather than from anything the pregnant person can feel.
Spontaneous TAPS
This type develops on its own in a shared placenta, without prior laser treatment. One twin gradually becomes anemic, which means too few red blood cells, while the other becomes polycythemic, meaning too many. During pregnancy, there may be few obvious symptoms, but scans can show one twin looking pale and stressed from anemia while the other has thicker blood and may appear more congested.
Post-laser TAPS
This type happens after laser treatment for twin-to-twin transfusion syndrome if a few tiny blood vessel connections remain. The basic pattern is the same, with one twin becoming anemic and the other polycythemic, but it appears in a pregnancy already being closely monitored for a serious placenta problem. Not everyone will experience every type.
Antenatal TAPS
This means twin anemia-polycythemia sequence is recognized before birth, usually through Doppler ultrasound showing different blood flow patterns in the twins' brains. Many pregnant people do not notice clear physical symptoms, though some may be told one twin is not growing as expected or that the pregnancy needs more frequent checks. The condition can range from mild to severe depending on how large the blood count difference becomes.
Postnatal TAPS
This means the condition is diagnosed after delivery, often when one newborn looks unusually pale and the other looks very red or plethoric. Blood tests show a large difference in hemoglobin between the twins, and the thicker blood in the polycythemic twin can make circulation sluggish. This form may be suspected if the pregnancy seemed fairly quiet but the twins look different soon after birth.
Can I slow down the onset of symptoms?
No, there is no good evidence that diet, activity, bed rest, or other lifestyle changes can meaningfully delay twin anemia-polycythemia sequence, which is a blood imbalance that can happen in twins who share one placenta. What does help is early and regular care with a high-risk pregnancy team, because repeated ultrasound and blood-flow checks in this kind of twin pregnancy can find changes early and guide treatment if needed, but this can lower the chance of serious problems rather than prevent the condition itself. While this is not something you can control on your own, close monitoring gives the best chance to respond quickly if it starts.
What genetics can tell you about symptoms
For twin anemia-polycythemia sequence, genetics usually does not tell doctors much about which symptoms will happen, how severe they will be, or when they will start, because this condition is mainly caused by an uneven flow of blood between identical twins who share one placenta. In most cases, the pattern of symptoms is linked more to the number and size of the placental blood vessel connections than to inherited genetic differences. Genetic testing may still be used in some pregnancies to look for other conditions that could affect a baby's health, but it does not usually explain or predict the symptoms of twin anemia-polycythemia sequence itself.
Causes and risk factors
Twin anemia-polycythemia sequence usually happens in identical twin pregnancies where both babies share one placenta. The main cause is a few tiny blood vessel connections in that placenta, and blood slowly moves from one twin to the other. Risk can also rise after laser treatment for twin-to-twin transfusion syndrome if very small connections remain. Researchers are still learning how these pieces fit together, but inherited genes are not known to be a major cause. Among risk factors for twin anemia-polycythemia sequence, food, exercise, and stress are not thought to play a major role.
What are the most common causes or risk factors?
The most important risk factor for twin anemia-polycythemia sequence is an identical twin pregnancy in which both babies share one placenta. The main cause is a few very small blood vessel connections in that shared placenta that slowly move blood from one twin to the other, so one twin can become anemic, meaning low on red blood cells, while the other ends up with too many. It can happen on its own or sometimes after laser treatment for another shared-placenta twin problem if tiny vessel connections remain, and it is not usually linked to inherited genes, diet, or anything the pregnant parent did.
Environmental and biological risk factors
Twin anemia-polycythemia sequence is a complication that can happen in some twins who share a placenta. Doctors often group risks into internal (biological) and external (environmental). For TAPS, the main risks are linked to how the shared placenta is built and whether tiny vessel connections remain after treatment. These are the main risk factors for twin anemia-polycythemia sequence.
Twin anemia-polycythemia sequence only occurs when twins share one placenta, called a monochorionic pregnancy. If each twin has a separate placenta, the vessel pattern needed for TAPS does not develop.
The main biological risk is a small number of very tiny blood-vessel connections in the placenta between the twins. These allow a slow, uneven blood transfer over time, which can leave one twin anemic and the other with too many red blood cells.
TAPS can develop after laser treatment for severe twin-to-twin transfusion syndrome if a few tiny placental vessel connections remain open. This is called post-laser TAPS and is a well-recognized risk setting.
Some pregnancies develop TAPS without any prior procedure. In these cases, the risk appears to come from the natural arrangement of placental blood vessels rather than anything the pregnant parent did day to day.
Genetic risk factors
When families ask about the genetic causes and risk factors for Twin anemia-polycythemia sequence, the main answer is that there is no well-established inherited gene change behind it. Instead, the biggest risk comes from a shared placenta in a monochorionic twin pregnancy, where tiny blood vessel connections can let blood move slowly from one twin to the other. In other words, this condition is usually tied more to how the placenta is formed than to something passed down through a family.
Inherited genes: Researchers have not identified a specific inherited mutation that causes Twin anemia-polycythemia sequence. In most families, it does not appear to be an inherited disorder passed from parent to child.
Shared placenta: Twin anemia-polycythemia sequence develops almost only in twins who share one placenta, which is called a monochorionic pregnancy. This shared circulation creates the setting that makes the condition possible.
Tiny vessel links: The direct cause is usually a small number of very tiny blood vessel connections in the placenta. These can allow a slow, uneven blood transfer, so one twin becomes anemic while the other develops too many red blood cells.
After laser treatment: Some cases happen after laser treatment for twin-to-twin transfusion syndrome if a few tiny placental connections remain. This is a recognized risk factor, but it is not a genetic one.
Family history: There is no strong evidence that family history meaningfully increases the chance of Twin anemia-polycythemia sequence. Routine parental genetic testing usually does not predict whether it will happen.
Lifestyle risk factors
Twin anemia-polycythemia sequence is not caused by parental lifestyle habits, but daily choices during a monochorionic twin pregnancy can still affect how quickly problems are noticed and how well complications are managed. In practice, how lifestyle affects Twin anemia-polycythemia sequence is mostly through support of placental function, fetal growth, and timely prenatal follow-up. Habits that reduce strain on the pregnancy and improve attendance at monitoring visits are the most relevant.
Missing ultrasounds or specialist appointments can delay detection of worsening anemia in one twin and polycythemia in the other. Keeping close fetal surveillance improves the chance of timely treatment, including referral for fetal therapy when needed.
Tobacco and nicotine do not cause Twin anemia-polycythemia sequence, but they can reduce placental blood flow and oxygen delivery during an already high-risk pregnancy. This may worsen fetal stress, growth problems, and the overall burden on both twins.
Alcohol and non-prescribed drug use can add fetal stress and make growth or neurologic outcomes worse in a pregnancy complicated by Twin anemia-polycythemia sequence. Avoiding these exposures helps limit extra risks on top of the shared-placenta problem.
Poor nutrition or inadequate hydration will not trigger the condition, but they can make it harder to support maternal health and steady fetal growth. A well-balanced intake with enough fluids can help the pregnancy tolerate intensive monitoring and possible procedures more safely.
Risk prevention
Twin anemia-polycythemia sequence is a pregnancy complication that can happen in identical twins who share one placenta. It cannot usually be fully prevented once that shared placenta has formed, so prevention mainly means lowering risk through close monitoring and timely treatment. Many living with a pregnancy affected by twin anemia-polycythemia sequence feel well at first, which is why regular scans matter even when there are no obvious warning signs. Prevention works best when combined with regular check-ups.
Seeing a maternity team early helps confirm whether twins share a placenta, which is the main setting where twin anemia-polycythemia sequence can develop. Early referral to a maternal-fetal medicine specialist can help set up the right monitoring plan from the start.
Frequent ultrasound visits during pregnancy can pick up early signs of twin anemia-polycythemia sequence before severe anemia or excess red blood cells cause harm. This is especially important because early symptoms of twin anemia-polycythemia sequence are often not noticeable to the pregnant person.
Blood-flow checks during ultrasound can show whether one twin may be becoming anemic while the other is developing thicker blood. These measurements help the care team decide if treatment is needed quickly.
Care from a center experienced in twin complications can reduce delays in diagnosis and treatment. Different people need different prevention strategies—there’s no single formula.
Can you prevent Twin anemia-polycythemia sequence?
Twin anemia-polycythemia sequence usually cannot be fully prevented, because it happens when twins who share one placenta have tiny blood vessel connections that can make blood flow unevenly between them. It is not caused by anything a pregnant person did or did not do. The best step is close care with a high-risk pregnancy specialist and regular ultrasound checks in shared-placenta twin pregnancies, which may help lower the chance of it being missed and allow earlier treatment if it happens.
Transmission
Twin anemia-polycythemia sequence is not an infection, so it cannot be caught, spread from one person to another, or passed around during pregnancy. It also is not usually inherited; when people ask about how Twin anemia-polycythemia sequence is inherited, the key point is that it happens in some identical twin pregnancies where both babies share one placenta and have tiny blood vessel connections between them.
In Twin anemia-polycythemia sequence, those very small placental connections let blood move unevenly from one twin to the other over time, leaving one twin with too little blood and the other with too much. It can develop on its own or sometimes after laser treatment for twin-to-twin transfusion syndrome, and it is not infectious at all.
When to test your genes
For twin anemia-polycythemia sequence, genetic testing is not routinely used for early detection or to guide treatment. Care is customized through close ultrasound monitoring, especially middle cerebral artery Doppler scans, and by checking the twins’ blood counts after birth. A genetics consult may be considered only if there are additional birth differences or another suspected condition.
Diagnosis
Twin anemia-polycythemia sequence is usually suspected during pregnancy when one twin appears anemic and the other appears to have too many red blood cells, even though there is often no major difference in amniotic fluid levels. Doctors usually begin with ultrasound and blood-flow checks, because the first clues often come from subtle changes rather than obvious symptoms. The diagnosis of Twin anemia-polycythemia sequence is then confirmed by combining scan findings with testing after birth or, in some cases, fetal blood sampling.
The main prenatal test measures blood flow in the middle cerebral artery of each twin. Faster flow in one twin can suggest anemia, while slower flow in the other can suggest polycythemia, making this a key clue to Twin anemia-polycythemia sequence.
Routine ultrasound also checks each baby's growth, movements, placenta, and amniotic fluid levels. In Twin anemia-polycythemia sequence, fluid levels may stay fairly normal, which helps doctors tell it apart from twin-to-twin transfusion syndrome.
Doctors look closely for signs that the twins share one placenta, because this condition happens in monochorionic pregnancies. The placental pattern helps explain how tiny blood-vessel connections can shift blood from one twin to the other.
In selected cases, your provider may suggest taking a small blood sample from the umbilical cord to look closer. This can directly confirm low hemoglobin in one twin and high hemoglobin in the other, but it is invasive so it is not used in every pregnancy.
How is Twin anemia-polycythemia sequence diagnosed?
Twin anemia-polycythemia sequence is usually diagnosed during pregnancy with regular ultrasound checks, including a special blood-flow scan that can show one twin has too few red blood cells and the other has too many. After birth, doctors can confirm it with blood tests that show a clear difference in the twins’ red blood cell levels, and sometimes by examining the shared placenta for tiny blood vessel connections between the babies.
Stages of Twin anemia-polycythemia sequence
Twin anemia-polycythemia sequence has recognized progression stages, most often used during pregnancy to describe how severe the blood imbalance is between twins sharing a placenta. In practice, doctors stage twin anemia-polycythemia sequence by ultrasound findings, especially blood-flow measurements in each baby’s brain, because these can show whether one twin is becoming anemic while the other has unusually concentrated blood. Many people feel reassured knowing what their tests can—and can’t—show. When people ask about the stages of twin anemia-polycythemia sequence, these stages mainly help the care team judge urgency and plan monitoring or treatment.
Stage 1
The blood-flow difference between the twins is present but still relatively mild. Both twins usually still show reassuring overall circulation on ultrasound.
Stage 2
The blood-flow difference becomes clearer and more concerning. This suggests the anemic twin and the polycythemic twin are moving further apart in severity.
Stage 3
The imbalance is now affecting blood flow in a way that suggests strain on one or both twins. Doctors usually see abnormal Doppler findings, which means closer monitoring or treatment is often needed.
Stage 4
One twin develops signs of fluid buildup, called hydrops, which is a marker of severe illness before birth. This means the anemia or circulation problem has become serious enough to affect the baby’s body more broadly.
Stage 5
One or both twins die before birth. This is the most severe stage and reflects critical progression of twin anemia-polycythemia sequence.
Outlook and prognosis
The outlook for twin anemia-polycythemia sequence varies with how early it is recognized, how severe the blood imbalance is, and whether treatment such as fetoscopic laser therapy, intrauterine transfusion, or partial exchange transfusion is possible. With timely diagnosis and management in experienced fetal medicine centers, survival of at least one twin is common and many pregnancies result in two surviving infants, although the anemic twin and the polycythemic twin can both face serious complications before or after birth. Risks include fetal heart strain, hydrops, neurologic injury, prematurity, and in severe untreated cases, death of one or both twins. Long-term prognosis is often good in survivors, but some children have neurodevelopmental impairment, particularly after severe antenatal compromise or very preterm delivery. Mortality rates differ widely between studies and depend on stage at diagnosis and treatment approach, so there is no single percentage that applies to all pregnancies. Close prenatal surveillance and specialized neonatal follow-up improve the chances of a better outcome.
Long-term effects
Twin anemia-polycythemia sequence can have lasting effects, but the outlook depends a lot on how early it is found, how severe it becomes, and whether the babies are born preterm. Some children have no major long-term problems, while others may need follow-up for development, hearing, or heart-related concerns. Doctors often describe these as long-term effects or chronic outcomes. When people ask about the long-term effects of twin anemia-polycythemia sequence, the main concerns are usually brain development, hearing, circulation, and complications linked to prematurity.
Reduced oxygen delivery before birth can affect the developing brain, especially in the twin with anemia. Some children later show delays with movement, learning, attention, or speech, although many develop typically.
Some babies, particularly donor twins with more severe anemia, have a higher risk of sensorineural hearing loss. This may not be obvious right away, so problems can first show up as delayed speech or trouble responding to sound.
The twin with extra red blood cells can have thicker blood and added strain on the heart and circulation. In most cases this improves after birth, but severe cases may leave a need for ongoing heart follow-up.
Many living with twin anemia-polycythemia sequence are born early, and some long-term issues come from prematurity as much as from TAPS itself. These can include breathing problems early on and later challenges with growth, feeding, or development.
How is it to live with Twin anemia-polycythemia sequence?
Living with twin anemia-polycythemia sequence often means a pregnancy that suddenly feels much more medicalized, with frequent ultrasounds, specialist visits, and the stress of watching closely for signs that one twin is becoming anemic while the other has too many red blood cells. For many families, daily life shifts around appointments, uncertainty, and decisions about treatment or early delivery, and after birth one or both babies may need close monitoring in the newborn period. This can be emotionally heavy for parents, partners, and siblings too, but careful follow-up with a fetal medicine team and neonatal team can make a real difference and help families feel more prepared.
Treatment and drugs
Treatment for twin anemia-polycythemia sequence depends on when it is found in pregnancy and how severe the blood imbalance is between the twins. Doctors watch the babies closely with ultrasound and blood-flow checks, and in many cases the main treatment is laser surgery on the placenta to seal the tiny shared blood vessel connections that are causing the problem; sometimes an exchange of blood before birth may also be considered in selected cases. If twin anemia-polycythemia sequence is diagnosed later in pregnancy or the babies seem stable, careful monitoring and planning the safest time for delivery may be enough. Not every treatment works the same way for every person, and after birth one or both babies may need treatment for anemia, high red blood cell levels, or jaundice in a neonatal unit. Early treatment for twin anemia-polycythemia sequence can improve outcomes, so regular specialist follow-up during pregnancy is an important part of care.
Can you cure Twin anemia-polycythemia sequence?
Twin anemia-polycythemia sequence does not have a simple guaranteed cure, but it can often be treated to lower the risk to both babies. Treatment depends on how severe it is and how far along the pregnancy is, and may include very close monitoring, a laser procedure on blood vessels in the shared placenta, blood treatment for one or both twins, or delivery at the safest time. After birth, some babies still need care to correct their blood levels and help with related problems.
Non-drug treatment
Treatment for twin anemia-polycythemia sequence usually centers on careful monitoring and procedures that improve blood flow problems between the twins or help doctors decide when birth is safest. Not every approach works the same way, because the best treatment for twin anemia-polycythemia sequence depends on how far along the pregnancy is and how severe the imbalance has become. For many, treatment begins not at the pharmacy, but in a fetal medicine unit with frequent ultrasound checks and a plan that can change quickly if either twin shows signs of strain.
Frequent ultrasounds and Doppler scans help the care team track anemia in one twin and overly thick blood in the other. This can mean repeat visits every few days or every week so changes are caught early and treatment is timed safely.
Fetoscopic laser treatment seals the small placental blood vessel connections that are driving twin anemia-polycythemia sequence. It aims to stop the ongoing blood imbalance and is most often considered when the condition is found before birth and appears to be worsening.
Some pregnancies are treated with an in-womb blood transfusion for the anemic twin, sometimes along with removal or dilution of excess red blood cells in the other twin. These procedures may help stabilize the babies, but they do not always fix the underlying placental vessel problem.
If the twins are far enough along or monitoring shows increasing risk, planned early delivery may be the safest option. This is often done in a hospital with neonatal specialists ready in case one or both babies need urgent care after birth.
Your genes may have an impact on how drugs work for you
For twin anemia-polycythemia sequence, gene differences do not usually play a big role in treatment because care is mostly based on close ultrasound checks, procedures to treat the blood flow problem, timing of delivery, and sometimes blood transfusions for the babies rather than medicines. If medicines are needed during pregnancy or after birth, people can still respond a little differently, but this is not a main part of care for many living with this condition. In other words, for TAPS, treatment decisions are usually driven by what is happening with the twins day to day, not by inherited differences in how the body handles drugs.
Pharmacological treatments
Twin anemia-polycythemia sequence is not usually treated with a medicine that fixes the condition itself. The main problem is an unbalanced blood flow between twins, so treatment often relies on close monitoring, laser treatment, transfusion procedures, or delivery rather than drugs. Medicines may still be used to support the pregnancy, especially if preterm birth is likely or a procedure is being planned. This can be confusing for families searching for treatment options for twin anemia-polycythemia sequence, because the most important treatments are often not medications.
Betamethasone or dexamethasone may be given during pregnancy if the babies are likely to be born early. These medicines help the babies’ lungs mature and can lower the risk of serious problems after preterm birth.
Tocolytic medicines such as nifedipine, indomethacin, or atosiban may sometimes be used for a short time if there are contractions or after a fetal procedure. They do not treat twin anemia-polycythemia sequence itself, but they can help delay labor long enough for monitoring, transfer, or steroid treatment.
Magnesium sulfate may be offered before very preterm delivery in some pregnancies. Sometimes medicines are taken short-term, and this one is used to help lower the risk of certain brain injuries in premature babies.
Local anesthetics and other pain-relief or sedation medicines may be used if a procedure such as fetoscopic laser treatment is performed. These drugs make the procedure safer and more tolerable, but they do not correct the blood imbalance on their own.
Genetic influences
When twin anemia-polycythemia sequence shows up in a pregnancy, many families immediately wonder whether it is hereditary. In most cases, twin anemia-polycythemia sequence is not thought to be caused by an inherited gene change passed down through a family. Instead, it usually happens in identical twin pregnancies where both babies share one placenta, and very small blood vessel connections let blood move slowly from one twin to the other over time. Genetics is only one piece of the puzzle, but for TAPS, the main issue is the way the shared placenta develops rather than a known single-gene disorder. That means the answer to questions about the genetic causes of twin anemia-polycythemia sequence is usually that there is no clear inherited cause. Doctors may still consider genetic testing if there are other unusual findings on ultrasound or concerns about growth or birth differences, but TAPS by itself does not usually point to a genetic condition.
Is Twin anemia-polycythemia sequence genetic?
Genetics are not thought to play a major role in Twin anemia-polycythemia sequence. It usually happens because of shared placental blood vessel connections in identical twins, rather than an inherited gene change.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are commonly found in the general population. Most do not directly affect health and are simply part of normal human diversity. For many genes, having a variant connected to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When Twin anemia-polycythemia sequence is found during pregnancy, treatment choices are usually based on how far along the pregnancy is and how severely each twin is affected, rather than on inherited gene differences. In practice, care often centers on procedures such as close monitoring, laser treatment of the blood vessel connections in the placenta, blood transfusion for the anemic twin, or planning delivery at the safest time. Not every difference in response is genetic, and with Twin anemia-polycythemia sequence, genetics are not currently a main tool for deciding which treatment is best. There also are no standard drug-gene tests used to guide medicines specifically for Twin anemia-polycythemia sequence, because the condition is mainly managed with fetal procedures and pregnancy-based decisions instead of long-term medication. Some medicines may still be used around treatment, such as drugs to support pregnancy or prepare for early delivery, but any genetic effect on those medications is not a well-established part of routine TAPS care. If you are wondering how genetics affect treatment for Twin anemia-polycythemia sequence, the most important point is that doctors usually rely on ultrasound findings, blood flow studies, and the twins’ condition rather than pharmacogenetic testing.
Interactions with other conditions
For families, twin anemia-polycythemia sequence can become more complicated when it appears alongside other problems in a shared-placenta twin pregnancy, especially twin-to-twin transfusion syndrome or selective fetal growth restriction, where one baby is much smaller than the other. These conditions can overlap because they are linked to abnormal blood vessel connections in the placenta, and together they may raise the chance of poor growth, heart strain, or distress in one or both babies. Doctors call it a “comorbidity” when two conditions occur together. In practice, this can make early symptoms of twin anemia-polycythemia sequence harder to spot, because changes seen on ultrasound or Doppler blood-flow checks may be due to more than one problem at the same time. Although twin anemia-polycythemia sequence mainly affects the babies rather than causing a separate maternal disease, the pregnancy still needs close monitoring because related complications such as preterm birth can become more likely.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Twin anemia-polycythemia sequence?
The main condition that can look similar is twin-to-twin transfusion syndrome, because both can happen in identical twins who share a placenta and both can affect blood flow, growth, and how each baby is doing. Doctors may also consider uneven placental sharing with one twin growing poorly, blood loss from one baby for other reasons, or other causes of anemia in one twin and unusually thick blood in the other.
History
For families expecting identical twins who share a placenta, one of the hardest parts can be hearing that a problem may develop even when scans had seemed reassuring. Twin anemia-polycythemia sequence, often shortened to TAPS, came to be recognized as doctors noticed a very uneven blood balance between twins: one twin becomes anemic, meaning too few red blood cells, while the other develops polycythemia, meaning too many. Unlike some other twin-to-twin complications, this may happen without a large difference in amniotic fluid, which is part of why it was not clearly identified at first.
In recent decades, awareness has grown as specialists in fetal medicine began separating TAPS from other conditions that affect twins sharing a placenta. Earlier on, many cases were probably grouped under broader twin transfusion problems or were only confirmed after birth, when one baby looked unusually pale and the other unusually red. As ultrasound methods improved, especially blood-flow measurements, doctors became better at spotting the pattern during pregnancy rather than only afterward.
That shift mattered in everyday care. It meant that many living with a high-risk twin pregnancy could be monitored more closely and, in some cases, treated before severe complications developed. Researchers also learned that TAPS can appear on its own or after treatment for twin-to-twin transfusion syndrome, which helped explain why some pregnancies seemed stable at first and then changed later.
The history of twin anemia-polycythemia sequence is also a story of more precise diagnosis. Initially understood only through symptoms, later it was recognized as a distinct condition with its own warning signs and follow-up needs. Over time, doctors refined the criteria used on ultrasound and after delivery, so the diagnosis became more consistent from one hospital to another.
Today, the history of TAPS shapes how specialists screen monochorionic twin pregnancies, especially when looking for early symptoms of twin anemia-polycythemia sequence on fetal ultrasound. Understandings have changed, but the main lesson has stayed the same: careful monitoring can make a real difference. Even though the condition is still considered uncommon, better recognition has helped families get clearer answers and more timely care than was possible in the past.